Ribonuclease activity in human plasma

doi:10.1016/S0009-9120(72)80033-X

Clinical Biochemistry

Volume 5, Issues 1–4, March 1972, Pages 198-200

https://doi.org/10.1016/S0009-9120(72)80033-X Get rights and content

Summary

1.
Utilizing a simple, rapid and inexpensive fluorometric method, the normal levels of ribonuclease (RNase) activity in human blood plasma were determined.
2.
An increase in RNase activity in a group of subjects over 30 years of age was found to occur in males, but not in females when compared to a group of subjects under 30 years of age.

References (5)

KammR.C. et al.
A fluorometric method for assay of RNase activity
Anal. Biochem.
(1970)
LepecqJ.B. et al.
A new fluorometric method for RNA and DNA determination
Anal. Biochem.
(1966)

There are more references available in the full text version of this article.

Cited by (30)

Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
2022, Current Research in Pharmacology and Drug Discovery
Citation Excerpt :
These indicators have become increasingly exact and trustworthy throughout time, owing to human technology developments. The assumption that RNA molecules could not be utilized as biomarkers from blood samples due to the elevated amounts of nucleases found in plasma was debated for a while (Kamm and Smith, 1972a,b), but it was eventually abandoned following the revealed as miRNAs remained resilient in samples of fixed tissues (Xi et al., 2007). In 2008, Lawrie et al. (2008) used miRNAs to analyze the serum of patients with diffuse large B-cell lymphoma as biomarkers for cancer; since then, potential major applications of miRNAs as biomarkers for several diseases has been discussed in the scientific literature.
Over the past few decades, thyroid cancer has become one of the most common types of endocrine cancer, contributing to an increase in prevalence. In the year 2020, there were 586,202 newly diagnosed cases of thyroid cancer around the world. This constituted approximately 3.0% of all patients diagnosed with cancer. The World Health Organization reported that there will be 2.3 million women receiving treatment for breast cancer in 2020, with 685,000. Despite the fact that carcinoma is one of the world's leading causes of death, there is still a paucity of information about its biology. MicroRNAs (miRNAs; miRs) are non-coding RNAs that can reduce gene expression by cleaving the 3′ untranslated regions of mRNA. These factors make them a potential protein translation inhibitor. Diverse biological mechanisms implicated in the genesis of cancer are modulated by miRNA. The investigation of global miRNA expression in cancer showed regulatory activity through up regulation and down-regulation in several cancers, including thyroid cancer and breast cancer. In thyroid cancer, miRNA influences several cancers related signaling pathways through modulating MAPK, PI3K, and the RAS pathway. In breast cancer, the regulatory activity of miRNA was played through the cyclin protein family, protein kinases and their inhibitors, and other growth promoters or suppressors, which modulated cell proliferation and cell cycle progression. This article's goal is to discuss key miRNA expressions that are involved in the development of thyroid and breast cancer as well as their therapeutic manipulation for these two specific cancer types.
Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
2021, Journal of Biological Chemistry
Functional delivery of mRNA has high clinical potential. Previous studies established that mRNAs can be delivered to cells in vitro and in vivo via RNA-loaded lipid nanoparticles (LNPs). Here we describe an alternative approach using exosomes, the only biologically normal nanovesicle. In contrast to LNPs, which elicited pronounced cellular toxicity, exosomes had no adverse effects in vitro or in vivo at any dose tested. Moreover, mRNA-loaded exosomes were characterized by efficient mRNA encapsulation (∼90%), high mRNA content, consistent size, and a polydispersity index under 0.2. Using an mRNA encoding the red light-emitting luciferase Antares2, we observed that mRNA-loaded exosomes were superior to mRNA-loaded LNPs at delivering functional mRNA into human cells in vitro. Injection of Antares2 mRNA-loaded exosomes also led to strong light emission following injection into the vitreous fluid of the eye or into the tissue of skeletal muscle in mice. Furthermore, we show that repeated injection of Antares2 mRNA-loaded exosomes drove sustained luciferase expression across six injections spanning at least 10 weeks, without evidence of signal attenuation or adverse injection site responses. Consistent with these findings, we observed that exosomes loaded with mRNAs encoding immunogenic forms of the SARS-CoV-2 Spike and Nucleocapsid proteins induced long-lasting cellular and humoral responses to both. Taken together, these results demonstrate that exosomes can be used to deliver functional mRNA to and into cells in vivo.
MicroRNAs in respiratory diseases
2019, Nucleic Acid Nanotheranostics: Biomedical Applications
MicroRNAs are noncoding RNAs of approximately 22 nucleotides that behave as key regulators of gene expression. They contain complementary sequences to the 3′-UTR region of specific mRNAs and bind to them, leading to a reduced mRNA translation or to mRNA degradation. Some microRNAs are released with exosomes, circulate in plasma, and may function in cell-to-cell communication. MicroRNAs play a fundamental role in developmental and physiological processes. In addition, up- or downregulation or mutation of miRNAs are involved in multiple diseases. Several microRNAs have been proposed as biomarkers of multiple respiratory diseases, including asthma, chronic obstructive pulmonary disease, lung cancer, fibrosis, pulmonary hypertension, acute respiratory distress syndrome, and obstructive sleep apnea. Moreover, by changing the normal pattern of protein expression, they may be involved in the pathophysiology of these diseases. Therefore, enhancing or decreasing microRNA function by using microRNA mimics or antagomirs, respectively, are innovative and promising therapeutic strategies.
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018, Trends in Microbiology
Citation Excerpt :
Microbes can release naked RNA into the environment upon cell death [23] or via active secretion systems [24]. However, RNAs in the extracellular environment can be rapidly degraded by abundant ribonucleases (RNases) [25]. Alternatively, engulfed viable and nonviable microbes might release RNA from within the host cell.
Both extracellular RNAs and extracellular vesicles (EVs) have recently garnered attention as novel mediators of intercellular communication in eukaryotes and prokaryotes alike. EVs not only permit export of RNA, but also facilitate delivery and trans-kingdom exchange of these and other biomolecules, for instance between microbes and their hosts. In this Opinion article, we propose that EV-mediated export of RNA represents a universal mechanism for interkingdom and intrakingdom communication that is conserved among bacterial, archaeal, and eukaryotic microbes. We speculate how microbes might use EV RNA to influence target cell gene expression or manipulate host immune responses.
Thematic Review Series: Functional Regulation of Lipid Homeostasis by microRNA: Extracellular communication via microRNA: Lipid particles have a new message
2013, Journal of Lipid Research
Citation Excerpt :
These findings open up a new and exciting frontier in our understanding of how miRNAs and other ncRNAs may be mediating cell-cell and even cross-kingdom communication. When RNA was first detected in the circulation in the early 1970s (40), it was immediately noted that despite the very high levels and activity of RNases present in human plasma, it was surprisingly resistant to nuclease degradation (41). This protection from nuclease degradation was also described for miRNAs in the circulation.
The complexity of microRNA (miRNA)-mediated pathway control has burgeoned since the discovery that miRNAs are found in the extracellular space and constitute a form of cell-cell communication. miRNAs have been found in plasma, urine, and saliva and have recently been shown to be carried on lipoproteins. This has led to the proposal that circulating miRNAs may be useful biomarkers of various diseases, including cardiovascular disease, diabetes, and other forms of dysregulated metabolism. Although our understanding of the cellular machinery responsible for the secretion of miRNA is incomplete, it has been demonstrated that miRNAs are packaged into exosomes, microvesicles, and apoptotic bodies by a broad range of cell types. Intriguingly, a large portion of extracellular miRNA is found outside of any lipid-containing vesicle, and instead is associated with RNA binding proteins like argonautes 1 and 2, which may aid in their protection from abundant nucleases in the extracellular space. The excitement for miRNAs as biomarkers is mounting as more and more evidence supports that these noncoding RNAs are actively secreted from diseased tissues, possibly before the onset of overt disease. While caution should be taken in these early days, there is little doubt that extracellular miRNAs will hold tremendous potential as both diagnostic and therapeutic agents.
Inducers and induction of interferons
1977, Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and

View all citing articles on Scopus

View full text

Ribonuclease activity in human plasma

Summary

Anal. Biochem.

Anal. Biochem.